Publications by authors named "Zu-Xuan Chen"

This study aimed to investigate the mechanisms of LACTB2 in colorectal cancer (CRC). Microarrays and sequencing data of CRC were acquired from UCSC Xena, GTEx, Gene Expression Omnibus, and TCGA. Pooled analysis of the mRNA expression of LACTB2 in CRC was performed using Stata software.

View Article and Find Full Text PDF

Background And Aim: The biological functions and clinical implications of lysophosphatidylcholine acyltransferase 1 (LPCAT1) remain unclarified in gastric cancer (GC). The aim of the current study was to explore the possible clinicopathological significance of LPCAT1 and its perspective mechanism in GC tissues.

Materials And Methods: The protein expression and mRNA levels of LPCAT1 were detected from in-house immunohistochemistry and public high-throughput RNA arrays and RNA sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • Triple-negative breast cancer (TNBC) is a tough type of breast cancer that doesn't have good ways to predict its behavior, so this study looks at two proteins called EZH1 and EZH2 to figure out how they work in TNBC.
  • The researchers used various tests and comparisons to see how EZH1 and EZH2 were expressed in TNBC tissues, and they also analyzed how these proteins might affect the cancer's growth and spread.
  • Results showed that EZH1 was lower in TNBC, while EZH2 was higher, which linked to certain genes involved in cell cycles and hormone responses, helping create a model to predict patient outcomes based on specific gene signatures.
View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) represents the third most common malignant tumor in the worldwide. Radiotherapy is the common therapeutic treatment for CRC, but radiation resistance is often encountered. ChIP-seq of Histone H3K27 acetylation (H3K27ac) has revealed enhancers that play an important role in CRC.

View Article and Find Full Text PDF

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients.

Results: Both protein and mRNA expression levels of BIRC5 are upregulated in ESCC group rather than non-ESCC group (standardized mean difference > 0).

View Article and Find Full Text PDF

The present study investigated the sensitization of 5-fluorouracil (5-FU)-resistant colon cancer cells , using oxymatrine, a Chinese herb, and a quinolizidine alkaloid compound extracted from the root of . The HCT-8 colon cancer cell line and its 5-FU-resistant subline HCT-8/5-FU were treated with 5-FU and oxymatrine, alone or in combination, at various doses. The cells were subsequently assessed for changes in cell viability, apoptosis and morphology and analyzed by fluorescence microscopy and western blotting.

View Article and Find Full Text PDF

Gastric adenocarcinoma (GAC) is a challenging disease with dim prognosis even after surgery; hence, novel treatments for GAC are in urgent need. The aim of the present study was to explore new potential compounds interfering with the key pathways related to GAC progression. The differentially expressed genes (DEGs) between GAC and adjacent tissues were identified from The Cancer Genome Atlas (TCGA) and Genotype‑Tissue Expression (GTEx) database.

View Article and Find Full Text PDF
Article Synopsis
  • - The meta-analysis aimed to investigate the role of Epstein-Barr virus (EBV) in the development of hepatobiliary system cancers like HCC, cholangiocarcinoma, and gallbladder carcinoma, given its association with other cancers but lack of systematic research in this area.
  • - A thorough search across multiple databases resulted in 15 studies being analyzed, which reported an overall EBV infection rate of 23% among patients with hepatobiliary cancers, with some variations across different cancer types.
  • - The findings suggest that EBV could be a potential risk factor for hepatobiliary cancers, although the exact molecular mechanisms remain unknown and require further study.
View Article and Find Full Text PDF

Background: It has been reported that deregulation or dysfunction of microRNAs (miRNAs) plays an essential part in the hepatocarcinogenesis. However, the contribution and mechanism of microRNA-30a-5p (miR-30a-5p) in hepatocellular carcinoma (HCC) remains largely unknown. Therefore, our aim was to investigate the clinicopathological role of miR-30a-5p in HCC tissues and explore its potential pathways in this study.

View Article and Find Full Text PDF